Biotage Unsponso Stock Price, News & Analysis

BITGY OTC Link

Company Description

Biotage Unsponso (OTC Link: BITGY) is a publicly traded testing laboratories company in the Professional, Scientific, and Technical Services sector.

This page provides a comprehensive overview of BITGY stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

$0.0

Market Cap

80.0M

Shares outstanding

Latest News

View All

February 15, 2023

—

Astrea Bioseparations to Combine with Biotage AB, Creating Global Chromatography Leader

March 14, 2022

—

Biotage AB (publ) publishes new Financial Goals

February 24, 2022

—

Biotage Awarded Gold Sustainability Medal by EcoVadis

February 11, 2022

—

Correction - Biotage and dividend proposal in the Swedish public announcement

dividends

February 11, 2022

—

Biotage AB (publ) Year-end report January - December 2021

January 3, 2022

—

Biotage moves to the large cap segment

Biotage Unsponso has 10 recent news articles. Key topics include dividends. View all BITGY news →

SEC Filings

View All

No SEC filings available for BITGY.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

BITGY Company Profile & Sector Positioning

Biotage Unsponso (BITGY) operates in the Testing Laboratories industry within the broader Professional, Scientific, and Technical Services sector and is listed on the OTC Link.